MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
AIkido Pharma P/B Ratio 2011-2026 | AIKI
Annual P/B Ratio AIkido Pharma
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.492 | 0.313 | 0.229 | 0.333 | 1.87 | 0.281 | 0.468 | 1.71 | 0.753 | 0.397 | 24.9 | 0.0115 | 0.678 | 1.17 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.17 K | 0.0115 | 85.5 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M |  Canada |
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | USA |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Adagene
ADAG
|
1.74 | $ 2.83 | -2.75 % | $ 159 M |  China |
 |
Biogen
BIIB
|
1.16 | $ 177.27 | 0.62 % | $ 25.8 B | USA |
 |
ANI Pharmaceuticals
ANIP
|
2.79 | $ 81.19 | -0.98 % | $ 1.57 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Amgen
AMGN
|
1.7 | $ 339.82 | -0.91 % | $ 182 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
BioNTech SE
BNTX
|
5.29 | $ 114.47 | -1.97 % | $ 27.2 B | Germany |
 |
Burford Capital Limited
BUR
|
1.26 | $ 9.65 | -0.16 % | $ 1.52 B |  Britain |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Aytu BioScience
AYTU
|
0.127 | $ 2.56 | -0.78 % | $ 16.1 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.23 | -0.92 % | $ 7.77 B |  Australia |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
CASI Pharmaceuticals
CASI
|
10.1 | $ 0.99 | - | $ 135 M | USA |
 |
Catalyst Biosciences
CBIO
|
0.428 | $ 10.0 | -1.43 % | $ 658 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | USA |
 |
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | USA |
 |
Cerus Corporation
CERS
|
5.29 | $ 2.3 | -1.08 % | $ 424 M | USA |
 |
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | USA |
 |
Cellectis S.A.
CLLS
|
0.531 | $ 3.81 | -4.51 % | $ 116 M | France |
 |
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | USA |
 |
Beam Therapeutics
BEAM
|
3.41 | $ 28.26 | -3.52 % | $ 2.33 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
8.34 | $ 223.79 | -0.07 % | $ 5 B |  Danmark |
 |
Athira Pharma
ATHA
|
0.36 | - | - | $ 269 M | USA |
 |
Atreca
BCEL
|
0.625 | - | -11.76 % | $ 5.79 M | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
4.51 | $ 68.89 | -0.33 % | $ 9.21 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
3.36 | $ 24.53 | -0.2 % | $ 2.91 B | USA |
 |
Cardiff Oncology
CRDF
|
2.34 | $ 1.68 | 3.75 % | $ 80.1 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
0.415 | - | -9.72 % | $ 5.89 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 4.03 | -1.71 % | $ 8.77 B |  Israel |
 |
Amneal Pharmaceuticals
AMRX
|
0.522 | $ 13.77 | -2.45 % | $ 4.25 B | USA |
 |
Bellerophon Therapeutics
BLPH
|
31 | - | -74.18 % | $ 955 K | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | USA |